Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
Min Young Baek, Jeong-Ju Yoo, Soung Won Jeong, Jae Young Jang, Yong Kwon Kim, Shin Ok Jeong, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Su Yeon Park
Korean J Intern Med. 2019;34(6):1223-1232.   Published online 2018 Oct 26     DOI: https://doi.org/10.3904/kjim.2018.058
Citations to this article as recorded by Crossref logo
Real world for management of hepatocellular carcinoma: a large population-based study
Supatsri Sethasine, Nitipon Simasingha, Sarita Ratana-Amornpin, Varocha Mahachai
Scandinavian Journal of Gastroenterology.2023; 58(10): 1153.     CrossRef
Risk Predictors of Post-Embolization Syndrome after Transarterial Chemoembolization by Sex: A Retrospective Study
Han Byeol Lim, Myoung Soo Kim
Korean Journal of Adult Nursing.2023; 35(4): 418.     CrossRef
Local recurrence following complete radiologic response in patients treated with transarterial chemoembolization for hepatocellular carcinoma
Shamar Young, Tina Sanghvi, Sandeep Sharma, Cameron Richardson, Nathan Rubin, Masters Richards, Donna D'Souza, Siobhan Flanagan, Jafar Golzarian
Diagnostic and Interventional Imaging.2022; 103(3): 143.     CrossRef
Metformin administration is associated with enhanced response to transarterial chemoembolization for hepatocellular carcinoma in type 2 diabetes patients
Woo Jin Jung, Sangmi Jang, Won Joon Choi, Jaewon Park, Gwang Hyeon Choi, Eun Sun Jang, Sook-Hyang Jeong, Won Seok Choi, Jae Hwan Lee, Chang Jin Yoon, Jin-Wook Kim
Scientific Reports.2022;[Epub]     CrossRef
Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma
Thomas J. Vogl, Linda J. Riegelbauer, Elsie Oppermann, Michel Kostantin, Hanns Ackermann, Annette Trzmiel, Stefan Stein, Katrin Eichler, Vladimir P. Zharov, Dhruvajyoti Roy, Andreas A. Schnitzbauer, Benjamin Strücker, Andreas Pascher, Wolf O. Bechstein, M
PLOS ONE.2021; 16(2): e0246527.     CrossRef
The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
Shou-Wu Lee, Teng-Yu Lee, Yu-Chi Cheng, Chieh-Ling Yen, Sheng Shun Yang
Medicine.2021; 100(26): e26414.     CrossRef
Utility of Real-time CT/MRI-US Automatic Fusion System Based on Vascular Matching in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: A Prospective Study
Seungchul Han, Jeong Min Lee, Dong Ho Lee, Jeong Hee Yoon, Won Chang
CardioVascular and Interventional Radiology.2021; 44(10): 1579.     CrossRef
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Cancers.2021; 14(1): 67.     CrossRef
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Young Chang, Soung Won Jeong, Jae Young Jang, Yong Jae Kim
International Journal of Molecular Sciences.2020; 21(21): 8165.     CrossRef
Potential prognostic factors for solitary hepatocellular carcinoma ≤ 5 cm after transarterial chemoembolization
Soon Young Ko, Won Hyeok Choe
The Korean Journal of Internal Medicine.2019; 34(6): 1210.     CrossRef